FDAAPP / ANNUAL

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Before July 2027Before October 2027Before Jan 1, 2027Before Mar 1, 2027Before 2028

Kalshi

Loading chart…

$14,903 vol

OutcomeChanceBuy

BJBefore July 2027

79%▼ 2

Yes 79¢No 21¢

BOBefore October 2027

90%

Yes 90¢No 10¢

BJBefore Jan 1, 2027

36%▲ 2

Yes 36¢No 64¢

Important information: If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.

Market Rules

Before July 2027

Resolves Yes if If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.

Note: this event is directional.

View full rulesHelp center

🗓️Timeline and payout

Contracts settle at $1.00 if the outcome resolves Yes, and $0.00 if it resolves No. Positions can be closed any time before expiration at the prevailing market price.

🚫Insider trading is prohibited

Contracts settle at $1.00 if the outcome resolves Yes, and $0.00 if it resolves No. Positions can be closed any time before expiration at the prevailing market price.